Social Media Ideas for Lewis Lung Carcinoma

Engineered Cytisine Derivative Disrupts Redox Balance to Kill Lung Cancer Cells

Lung cancer continues to claim roughly 1.76 million lives each year, and while chemotherapy has extended survival for many patients, its impact is blunted by severe side effects an...

FDA-approved pancreatic cancer drug Rasonque shows promise in lung cancer trial

BATON ROUGE — A drug recently approved by the FDA for pancreatic cancer is now showing promise in early-stage lung cancer trials.The drug, Rasonque, was FDA-approved for...

mRNA Vaccine Paired With Radiotherapy Shrinks HER2-Positive Lung Tumors in Mice

A HER2-targeted mRNA lipid nanoparticle vaccine combined with fractionated radiotherapy suppressed tumor growth and reprogrammed the immune microenvironment in a mouse model of HER...

Small Cell Lung Cancer Relies on Targetable Nonsense-Mediated Decay for Immune Control

A Hidden RNA-Decay System May Be the Achilles’ Heel of Small-Cell Lung Cancer Small-cell lung cancer, one of the most aggressive forms of cancer, may depend on a cellular quality-c...

Immune Cells Cluster Around Blood Vessels to Predict Lung Cancer Immunotherapy Success

Immunotherapy has transformed the treatment landscape for non-small cell lung cancer, the most common form of lung malignancy worldwide, yet a stubborn problem persists: only a sub...

An overlooked immune cell offers a way to treat deadliest lung cancers

An overlooked population of immune cells could offer a new way to attack one of the deadliest forms of lung cancer.Continue ReadingCatego...

Integrating Lymph Node Metastasis and Programmed Death-Ligand 1 Prediction in Non–Small Cell Lung Cancer From a Single P...

Background: Preoperative stratification for non–small cell lung cancer (NSCLC) necessitates separate evaluations of lymph node metastasis (LNM) to guide surgical decisions and of p...

Scientists Discover Hidden Cells That Help Lung Cancer Evade the Immune System

Newly identified CHL1 fibroblasts may help lung cancers escape immune attack by recruiting regulatory T cells around tumors. A previously unknown population of fibroblasts appears...

Daraxonrasib shows early antitumor activity in RAS-mutant lung cancer

Daraxonrasib, Revolution Medicines tarafından geliştirilen deneysel bir oral RAS inhibitörü, ameliyat dışı NSCLC olgularının yaklaşık üçte birini oluşturan ve PD-1 ek...

Human multi-organ chip tracks breast cancer spread to bone and lung

By: Columbia University School of Engineering and Applied Science From: medicalxpress.com Cancer spreading beyond the primary tumor—a process known as metastasis—is responsible for...

A New World of Lung Cancer Therapy Awaits Pope Leo

Lung cancer is still a leading cause of cancer death, but that rate is half what it was in the 1990s, partly because newly developed treatments are working.

This Rare Gene Drastically Raises Lung Cancer Risk in People Who Never Smoked

The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found.

Summit’s ivonescimab cuts death risk by 27% versus Keytruda in lung cancer trial

B7-H3 ADCs: A new contender in small cell lung cancer and beyond 

Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer as Hansoh Pharma and Medilink bring momentum with positive results. The post B7-H3 ADCs: A new contender in small...

WVU Medicine team performs innovative surgery to treat lung cancer

MORGANTOWN – Lung cancer is one of the leading causes of cancer-related deaths worldwide. In West Virginia, smoking and lung cancer rates are significantly higher than the national...

Roy Castle Lung Cancer Foundation

http://www.roycastle.org/

WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlight

The year’s biggest meeting on lung cancer research featured data suggesting a new treatment standard for an aggressive tumor as well as debate about the reliability of results from...

CT and biomarkers support small cell lung cancer diagnosis in unbiopsied patient

A two-case report found that characteristic CT findings, markedly elevated NSE and multidisciplinary review enabled an image-supported small cell lung cancer diagnosis and treatmen...

WCLC 2026: The lung cancer drug development readouts that caught our eye 

Find out what came out of the World Conference on Lung Cancer (WCLC) 2026, from late-stage successes and failures to earlier-stage promise. The post WCLC 2026: The lung cancer drug...

Survival From Lung Cancer, Including the Type That Pope Leo XIV Has, Continues to Improve Thanks to Sustained Cancer Res...

Like millions of people, Pope Leo XIV was diagnosed with lung cancer. This disease, though still serious, has also been transformed from one of daunting odds to a surmountable affl...

Rare EGFR mutation sharply raises lung cancer risk in large genetic study

An observational study of 3.3 million research participants found that inherited EGFR T790M was associated with 25-fold higher lung cancer risk overall and more than 60-fold risk a...

PARP Inhibitor Combination Therapy Boosts Antitumor Activity in NSCLC Models

Pairing HER3-DXd with the PARP inhibitor olaparib increased DNA damage, induced apoptosis, and slowed tumor progression in vivo in preclinical non-small cell lung cancer models. Th...

Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests

A breakthrough drug recently approved to treat advanced pancreatic cancer may show promise against lung cancer as well, a new study suggests.

Rare Giant Lung Tumour With Suspected Liver Spread Challenges Diagnosis and Treatment

A case report describes a 57-year-old woman with a giant intrapulmonary solitary fibrous tumour exceeding 16 centimetres, complicated by suspected liver metastasis and treated with...